Cargando…
Candida auris screening practices at healthcare facilities in the United States: A survey of the Emerging Infections Network
Background: Candida auris, an emerging fungal pathogen, is frequently drug resistant and spreads rapidly in healthcare facilities. Screening to identify patients colonized with C. auris can prevent further spread by prompting aggressive infection prevention and control measures. The CDC recommends C...
Autores principales: | Hennessee, Ian, Forsberg, Kaitlin, Beekmann, Susan E., Polgreen, Philip, Gold, Jeremy, Lyman, Meghan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594336/ http://dx.doi.org/10.1017/ash.2023.371 |
Ejemplares similares
-
Candida auris‒Associated Hospitalizations, United States, 2017–2022
por: Benedict, Kaitlin, et al.
Publicado: (2023) -
Screening for Candida auris in patients admitted to eight intensive care units in England, 2017 to 2018
por: Sharp, Ashley, et al.
Publicado: (2021) -
Colonization screening positivity rates for novel multidrug-resistant organism healthcare containment responses during 2019–2022
por: Rankin, Danielle, et al.
Publicado: (2023) -
174. Increase in Candida auris cases in New Jersey healthcare facilities during the COVID-19 pandemic — 2017–2020
por: Magleby, Reed, et al.
Publicado: (2021) -
Use of contact precautions for multidrug-resistant organisms and the impact of the COVID-19 pandemic: An Emerging Infections Network (EIN) survey
por: Howard-Anderson, Jessica, et al.
Publicado: (2023)